Suchergebnisse - "Becerra, Carlos R"

PubPharm (52)

1

Author Correction : Targeting LIF-mediated paracrine interaction for pancreatic cancer therapy and monitoring

enthalten in: Nature | 2021

von Shi, Y. | Gao, W. | Lytle, N. | +35

ErratumFor: Nature. 2019 May;569(7754):131-135. - PMID 30996350

2

A phase I, open-label study evaluating the safety and pharmacokinetics of trifluridine/tipiracil in patients with advanced solid tumors and varying degrees of renal impairment

enthalten in: Cancer chemotherapy and pharmacology | 2021

von Saif, M. | Becerra, C. | Fakih, M. | +14

3

A phase I, open-label study evaluating the safety and pharmacokinetics of trifluridine/tipiracil in patients with advanced solid tumors and varying degrees of renal impairment

enthalten in: Cancer chemotherapy and pharmacology | 2021

von Saif, M. | Becerra, C. | Fakih, M. | +14

4

A phase I, open-label study evaluating the safety and pharmacokinetics of trifluridine/tipiracil in patients with advanced solid tumors and varying degrees of renal impairment

enthalten in: Cancer chemotherapy and pharmacology | 2021

von Saif, M. | Becerra, C. | Fakih, M. | +14

5

A phase I, open-label study evaluating the safety and pharmacokinetics of trifluridine/tipiracil in patients with advanced solid tumors and varying degrees of renal impairment

enthalten in: Cancer chemotherapy and pharmacology | 2021

von Saif, M. | Becerra, C. | Fakih, M. | +14

6

Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours

enthalten in: British journal of cancer | 2020

von Hong, D. | Kang, Y. | Borad, M. | +20

7

Targeting LIF-mediated paracrine interaction for pancreatic cancer therapy and monitoring

enthalten in: Nature | 2019

von Shi, Y. | Gao, W. | Lytle, N. | +35

ErratumIn: Nature. 2021 Dec;600(7889):E18. - PMID 34848876

8

Locally advanced carcinosarcoma of the pancreas

enthalten in: Proceedings (Baylor University. Medical Center) | 2018

von Still, S. | Becerra, C. | Clement-Kruzel, S. | +1

9

A Phase 1, Open-Label, Randomized, Crossover Study Evaluating the Bioavailability of TAS-102 (Trifluridine/Tipiracil) Tablets Relative to an Oral Solution Containing Equivalent Amounts of Trifluridine and Tipiracil

enthalten in: Journal of clinical pharmacology | 2017

von Becerra, C. | Yoshida, K. | Mizuguchi, H. | +2

10

Patient-reported Symptoms of Tenosynovial Giant Cell Tumors

enthalten in: Clinical therapeutics | 2016

von Gelhorn, H. | Tong, S. | McQuarrie, K. | +18

1
2
3
4
5
6
Nächster »
[6]